Related Experiment Videos
Fusobacterium nucleatum, a new invasive pathogen in neutropenic patients?
P M Landsaat1, H van der Lelie, G Bongaerts
1Department of Internal Medicine and Hematology, Academic Medical Centre, Amsterdam, The Netherlands.
Abstract:
Three chemotherapy-induced neutropenic hematologic patients with severe systemic infection caused by Fusobacterium nucleatum, a Gram-negative anaerobic rod, are described. Anaerobic infections are not very common in this patient category, but in a short period of time, several such patients were seen. The infection was considered to be caused by a combination of chemotherapy-induced mucositis, which served as a portal of entry for the systemic infection, and the antibiotic regime used in these patients. This is a serious infection with a high mortality. In hematological neutropenic patients suffering from severe mucositis and fever, antibiotic therapy should cover anaerobic bacteria.
Insights
Severe systemic infections caused by Fusobacterium nucleatum are rare in chemotherapy patients. Antibiotic therapy for neutropenic patients with mucositis and fever should include coverage for anaerobic bacteria.
Area of Science:
- Hematology
- Infectious Diseases
- Oncology
Background:
- Chemotherapy can lead to neutropenia and mucositis, increasing infection risk.
- Fusobacterium nucleatum, a Gram-negative anaerobic rod, can cause severe systemic infections.
- Anaerobic infections are uncommon but serious in neutropenic patients.
Observation:
- Three cases of severe systemic infection by Fusobacterium nucleatum in chemotherapy-induced neutropenic hematologic patients were observed.
- The infections were linked to chemotherapy-induced mucositis acting as an entry point and the patients' antibiotic regimens.
Findings:
- Fusobacterium nucleatum caused severe systemic infections in these neutropenic patients.
- Chemotherapy-induced mucositis and antibiotic use were contributing factors.
- These infections present a high mortality risk.
Implications:
- Hematologic patients with neutropenia, mucositis, and fever require antibiotic therapy that covers anaerobic bacteria.
- Early recognition and appropriate antibiotic selection are crucial for managing these severe infections.
- Further research into the specific role of Fusobacterium nucleatum in neutropenic patients is warranted.